Recovery of extracellular vesicles from human breast milk is influenced by sample collection and vesicle isolation procedures by Marijke I. Zonneveld et al.
ORIGINAL RESEARCH ARTICLE
Recovery of extracellular vesicles from human breast
milk is inﬂuenced by sample collection and vesicle
isolation procedures
Marijke I. Zonneveld
1,2, Alain R. Brisson
3, Martijn J. C. van Herwijnen
2,
Sisareuth Tan
3, Chris H. A. van de Lest
2, Frank A. Redegeld
1,
Johan Garssen
1,4, Marca H. M. Wauben
2 and Esther N. M. Nolte-’t Hoen
2*
1Division of Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University,
Utrecht, The Netherlands;
2Department of Biochemistry & Cell Biology, Faculty of Veterinary Medicine,
Utrecht University, Utrecht, The Netherlands;
3Imagerie Mole ´culaire et NanoBioTechnologie, UMR-CBMN
CNRS-University of Bordeaux, Pessac, France;
4Nutricia Research Centre for Specialized Nutrition, Utrecht,
The Netherlands
Extracellular vesicles (EV) in breast milk carry immune relevant proteins and could play an important role in the
instructionoftheneonatalimmunesystem.TofurtheranalyzetheseEVandtoelucidatetheirfunctionitisimportant
thatnativepopulationsofEVcanberecoveredfrom(stored)breastmilksamplesinareproduciblefashion.However,
the impact of isolation and storage procedures on recoveryof breast milk EV has remained underexposed. Here, we
aimed to define parameters important for EV recovery from fresh and stored breast milk. To compare various
protocols across different donors, breast milk was spikedwith awell-defined murine EV population. We found that
centrifugation of EV down into density gradients largely improved density-based separation and isolation of EV,
compared to floatation up into gradients after high-force pelleting of EV. Using cryo-electron microscopy, we
identified different subpopulations of human breast milk EV and a not previously described population of lipid
tubules. Additionally, the impact of cold storage on breast milk EV was investigated. We determined that storing
unprocessed breast milk at 808Co r4 8C caused death of cells present in breast milk, leading to contamination of
thebreastmilkEVpopula tionwithstorage-inducedEV .Here,analternativemethodisproposedtostorebreastmilk
samples for EVanalysis at later time points. The proposed adaptations to the breast milk storage and EV isolation
procedures can be applied for EV-based biomarker profiling of breast milk and functional analysis of the role of
breast milk EV in the development of the neonatal immune system.
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B
reast milk not only functions as a source of nutri-
tion but also delivers immune modulatory factors
to neonates. Breast milk components relevant to
immunity include cytokines, antibodies, multiple types of
immune cells, antimicrobial peptides, microbes, and un-
ique lipids (reviewed in (14)). Components such as IgA
and IgG have been shown to modulate immune reactivity
of the child to antigens present in the environment (5,6).
Breast milk is therefore thought to play an important role
in the development of the immune system of the child.
Direct evidence that the composition of breast milk can
influence immune responses in neonates was provided in
mouse models of allergic asthma and food allergy (7,8). In
these studies, offspring was breastfed by mothers exposed
to inhaled or food antigens. It was shown that this
offspring exhibited profoundly reduced immune reactions
to these antigens. The mechanism behind this type of
immune modulationviabreast milk is not understood, but
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tolerance and regulatory T cells.
Recently,extracellularvesicles(EV)havebeenidentified
in human breast milk (911) and in bovine milk (12,13).
EV are released by many different cell types and are
recognized as potent vehicles for intercellular communica-
tion, capable oftransferring messages encoded in proteins,
lipids and RNA. The majority of EV are B200 nm in
size and typically consist of lipid bilayer enclosed vesicles.
The cargo of EV is regulated by the EV producing cells
and depends on activation- and stress-stimuli imposed
on these cells (14,15). EV derived from different cell
types can influence various biological processes, with EV
from leukocytes playing an active role in the regulation of
innate and adaptive immune responses (15). It is cur-
rently unknown whether the EV in breast milk originate
from cells present in milk, from epithelial cells lining the
mammary gland or from cells elsewhere in the body. A
potential role for milk-derived EV in immune modulation
wassuggestedbasedontheirproteinandmiRNAcontents
(9,1113). Moreover,humanbreastmilkderivedEVwere
found to facilitate regulatory Tcell induction (9). This has
led to the hypothesis that EV in breast milk could be
involvedintheinstructionoftheneonatalimmunesystem.
General protocols to isolate EV from cell culture
supernatants or body fluids involve steps of differential
(ultra)centrifugation and further purification on a density
gradient. However, since different body fluids have a
highly variable composition, each of the isolation proto-
cols to recover EV from these body fluids may require
specific optimization steps (16). Factors that could com-
plicate isolation of EV from milk are the high fat and
protein content of this body fluid. Most of the fat is stored
in milk fat globules (MFG), which are lipid droplets that
are formed and secreted by the epithelial cells lining the
mammary gland (17). Major milk proteins are casein and
whey (18). The tertiary structures of these proteins add to
the complexity of the milk matrix, as casein is organized
into micelles (19), while whey consists of globular proteins
known for their emulsifying capacities (20). Besides the
complex milk matrix, storage protocols could also affect
recovery of EV from breast milk. Previous studies used
refrigerated or frozen milk as a source for EV (912,21
24).Coldstorageofmilkiscommonpracticeandeffectson
nutritional components and soluble immunological fac-
tors have been described (2527). However, storage effects
on cells and EV populations in breast milk have mostly
been ignored (28). Since disintegration of dead cells leads
to the formation of membrane-enclosed vesicles (29), cell
death can lead to contamination of the pool of naturally
present EV with vesicles induced upon sample storage.
Here, we assessed and optimized the efficiency and
reproducibility with which EV can be recovered from breast
milk samples. To this end, milk samples were spiked with
a well-characterized mouse EV population as an internal
standard.Thecommonlyuseddifferentialcentrifugationand
density gradient ultracentrifugation protocol was modified,
in order to achieve efficient and quantitative recovery of
EV from breast milk. Additionally, we show that cells in
refrigeratedorfrozenbreastmilksamplesdierapidly,leading
to contamination of the native milk EV population with
vesiclesderivedfromdyingordeadcells.Thus,weprovidean
alternative method for the storage of breast milk samples
for efficient and reliable recovery of EVat later time points.
Materials and methods
Breast milk collection
Fresh, mature milk samples were collected by 17 healthy
mothers (atB8 months (15 donors) or 1120 months
(2 donors) after delivery), who were not actively terminat-
ing breast feeding. Donors were instructed to collect fore
and hind milk of 1 breast using an electric breast pump,
and to gently mix and aliquot 1050 ml of milk in sterile
containers. Milk was transported to the lab and used
for experiments within 20 minutes of collection. Milk
was prevented from cooling down by transportation in
a Styrofoam box, insulated with tissues and containing
a heat-generating package. All donors gave their signed
informed consent to participate and the study was
approved by the local ethics committee.
Preparation of BMDC for spiking of milk samples
Murine bone marrowderived dendritic cells (BMDC)
used for spiking of breast milk samples were generated
from C57BL/6 mice as described previously (30,31). Cells
were cultured in EV-depleted culture medium, prepared
by centrifuging solutions of 30% FCS in IMDM and
conditioned medium from GM-CSF producing R1 cells
for 15 hours at 100,000 g. On day 14, cells were harvested,
counted, washed twice in PBS containing 1% vesicle-
depleted FCS, and finally resuspended in PBS/1% FCS at
a concentration of 1510
6 cells/ml. Vesicle-depleted FCS
was obtained by 65 minutes centrifugation at 100,000 g
(Beckman Coulter Optima L-90K using a SW28 rotor).
Preparation of murine reference EV for spiking of
milk samples
Murine EV were obtained by cognate co-culture of
the immature DC-line D1 with p53-specific CD4
-T
cells derived from a C57BL/6 p53
/ mouse, as described
previously (32). Briefly, supernatant was harvested after
20 hours of co-culture and centrifuged 2200 g and
2500gfor10minutes,10,000gfor30minutes(Beckman
CoulterAvantiJ-26XPusingaJA-12rotor),and100,000g
for 65 minutes (Beckman Coulter Optima L-90K ultra-
centrifuge using a SW28 rotor). All centrifugation steps
were performed at 48C. The 100,000 g pellet was resus-
pended in PBS supplemented with 0.2% BSA which had
been ultracentrifuged O/N at 100,000 g. This EV suspen-
sion was used immediately for spiking of breast milk
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6
T cells were used. Recovery of these reference EV was
calculated as apercentage of the total numberof reference
EV in control conditions in each individual experiment.
Breast milk EV isolation
Fresh breast milk samples were spiked with murine
reference EV and gently inverted to mix or were left
unspiked. Milk was centrifuged at RT for 10 minutes at
3,000 g (Beckman Coulter Allegra X-12R) to remove cells
and cream layer (Supplementary Fig. 1). Supernatant was
then transferred to new tubes and centrifuged again
at 3,000 g at RT to remove remaining cells and cream.
The supernatant was then either immediately processed
or frozen at 808C. If frozen milk samples were used,
they were thawed in a 378C water bath until a small clump
oficeremainedandusedimmediately.Thefreshorthawed
milk supernatants were subsequently transferred to poly-
allomer SW40 tubes (Beckman Coulter) and centrifuged
at 5,000 g for 30 minutes at 48C to remove larger cell
debris and residual cream, and subsequently at 10,000 g
for 30 minutes at 48C to remove smaller cell debris.
For top-down ultracentrifugation (Supplementary Fig. 1,
left side), 6.5 ml of the cleared 10,000 g milk superna-
tant was loaded on top of a sucrose density gradient in
an SW40 tube. This density gradient was prepared
by layering successive sucrose solutions (15 fractions
of 350 ml) of decreasing density (2.0 M0.4 M) on top of
700 ml 2.5 M sucrose. For bottom-up density gradient
ultracentrifugation (Supplementary Fig. 1, right side),
9.0mlofthecleared10,000gmilksupernatantwaslayered
on top of a 2-step cushion of 2.0 M and 0.74 M sucrose
in an SW40 tube and centrifuged at 100,000 g for
125 minutes. The interphase between the sucrose layers
was harvested using a 21G syringe, dilutedwith PBS/0.1%
O/N ultracentrifuged BSA, and pelleted at 100,000 g for
65 minutes. The pellet was resuspended in PBS/0.2%
ultracentrifuged BSA, mixed with 1.5 ml 2.5 M sucrose,
and overlaidwith sucrose solutions (15 fractions of 750 ml)
of decreasing density (2.0 M0.4 M). Both top-down
and bottom-up density gradients were ultracentrifuged
for 1421 hours at 192,000 g (Beckman Coulter Optima
L-90K with a SW40 rotor). Density fractions of 0.5 ml
(top-down) or 1 ml (bottom-up) were collected from the
bottom of the tube in Eppendorf tubes. Densities were
determined by refractometry.
Cryo-electron microscopy
For cryo-electron microscopy (cryo-EM), fractions of
indicated densities were pooled and diluted with Annexin
V-binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM
CaCl2, pH 7.4), supplemented with 0.1% ultracentrifuged
BSA. Material was pelleted at 100,000 g for 65 minutes
using an SW40 rotor and pelletswere resuspended in 50 ml
Annexin V-binding buffer/0.1% ultracentrifuged BSA and
kept at 48C prior to Annexin V labeling and processing.
For cryo-EM Annexin V labeling, a 7 mL aliquot was
mixed with 1 ml Annexin V-conjugated gold nanoparticles
at 210
16 particles/l (33) and 1 ml 2 mM CaCl2 and
incubated for 15 minutes at RT. Then, a 4 mL aliquot was
deposited onto an EM grid coated with a perforated
carbon film (Ted Pella, Redding, CA, USA), the excess
liquid was blotted off with filter paper, and the grid was
quickly plunged into liquid ethane using a Leica EM-CPC
cryo-chamber. EM grids were stored in cryo-boxes under
liquid nitrogen until use, then mounted in a Gatan 626
cryo-holder and transferred in a Tecnai F20 microscope
operated at 200 kV. Images were recorded with an
USC1000-SSCCD Gatan camera.
SDS-PAGE, Coomassie staining, and western
blotting
Density fractions were either pooled or processed in-
dividually, as indicated. Fractions were diluted with PBS/
0.1% ultracentrifuged BSA and pelleted at 100,000 g for
65 minutes in a Beckman Coulter Optima L-90K, using
a SW60 rotor for individual fractions and a SW40 rotor
for pools. Pellets were resuspended in non-reducing
SDS-PAGE sample buffer, heated at 1008C for 3 minutes
and run on a 420% TGX-Criterion gel (Bio-Rad,
Hercules, CA, USA). Gels were stained with Coomassie
brilliant blue solution or transferred to PVDF mem-
branes and blocked in PBS containing 0.2% fish skin
gelatin and 0.1% Tween-20. Proteins were detected by
immunoblotting using rat anti-mouse CD9 (KMC8,
eBioscience, Vienna, Austria), rat anti-mouse CD63
(R5G2, MBL, Woburn, MA, USA), rabbit anti-mouse
MHC class II (polyclonal, Genscript, Piscataway, NJ,
USA), mouse anti-human CD9 (HI9a, BioLegend, Fell,
Germany), mouse anti-human flotillin-1 (clone 18, BD
Biosciences, San Jose, CA, USA), mouse anti-HLA-DP/
DQ/DR (CR3/43, Dako, Heverlee, Belgium), mouse anti-
human CD63 (TS63, Abcam, Cambridge, UK), rabbit
anti-human b-casein (polyclonal, Abcam), rabbit anti-
human lactoferrin (polyclonal, Abcam), and rabbit
anti-human a-lactalbumin (EPR12460, Abcam). Second-
ary antibodies goat anti-mouse-HRP (Jackson Immuno
Research, Suffolk, UK), rabbit anti-rat-HRP, and goat
anti-rabbit-HRP (both from Dako) were used. Labeled
antibodies were detected using SuperSignal West Dura
Chemiluminescent Substrate (Thermo Scientific, Land-
smeer, Netherlands). Protein levels were quantified by
densitometry using a ChemiDoc XRS and Quantity One
Basic software V4.6.9 (Bio-Rad).
Cellular viability assessment
Fresh breast milk was spiked with murine BMDC at
a final concentration of 0.7510
6 cells/ml or was left
unspiked. Milk was divided into equal volumes and was
either processed immediately or stored at 808C, 48C,
RT or 378C for the indicated time periods. Breast milk
EV from human breast milk
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were resuspended andwashed twice in IMDM containing
5% FCS and centrifuged at 500 g for 10 minutes.
Cell pellets were resuspended in PBS/1% FCS. Cellular
viability was determined by trypan blue exclusion.
Alternatively,cellswereincubatedwithAPC-conjugated
anti-mouse MHC class II (M5/114, eBioscience) or the
corresponding isotype control, or Alexa488-conjugated
AnnexinV(LifeTechnologies,Bleiswijk,Netherlands)and
propidium iodide (PI; eBioscience) as indicated by manu-
facturer. Cells were analyzed using a FACS Canto II and
FACS Diva software (BD Biosciences), and FCS Express
software (De Novo software, Los Angeles, CA, USA).
Murine cell viability was determined by gating on MHC
class II positive cells, and determining the percentage of
Annexin V and/or PI positive cells.
Storage of milk supernatant cleared from cells
and cream
Fresh breast milk was spiked with murine reference EV,
as indicated above, and gently inverted to mix. Milk was
centrifuged at 3,000 g for 10 minutes at RT. Subsequently,
the cream layer was removed and the supernatant was
transferred to a new tube. Supernatant was then centri-
fuged again at 3,000 g for 10 minutes at RT, after which
milk was divided into equal volumes and stored for 28
weeks at 808C.
Statistics
Normal distribution of data was determined using the
Shapiro-Wilk normality test. Normally distributed data
wereanalyzed by 1 samplet-test, relativetocontrol values,
whichweresetto100%,otherwiseaWilcoxonsigned-rank
test was used. Normally distributed paired data were
analyzed using a paired t-test. If multiple parameters
were compared, 1-way ANOVA was applied, followed
by Tukey’s post hoc test. Significance was defined as
*pB0.05 and **pB0.01, and calculated with GraphPad
Prism software V6.02.
Results
Differential centrifugation followed by top-down
density gradient ultracentrifugation allows efficient
density separation of EV from breast milk
Differential (ultra)centrifugation followed by density
gradient ultracentrifugation is a common protocol used
for EV isolation from cell culture supernatant (34,35).
Although this procedure has been used in previous
studies on breast milk EV, the efficiency with which EV
can be isolated from milk using this procedure has not
been assessed. Determining such efficiency, however, is
hampered by the lack of knowledge on markers char-
acteristic for milk EV, and by the large differences in
milk composition observed between individuals and even
between feeds of the same individual (3638). In order to
optimize EV isolation from breast milk, fresh human
milk was spiked with a known population of murine
EV (hereafter referred to as ref-EV) as an internal
standard, prior to the centrifugation procedure. These
ref-EV consisted of EV released during in vitro co-culture
of murine DC with T cells, which were previously found
to be enriched in CD9 and CD63 (32,39 and data not
shown). Based on earlier observations that characteristics
such as size ( 50150 nm) and density (1.121.18 g/ml)
appear common to EV throughout species and body
fluids, we assumed that the ref-EV and human breast
milk EV behaved similarly with regard to sedimentation
and density separation (40).
First, the spiked breast milk was subjected to the
conventional protocol of differential centrifugation, in
which unwanted components are removed in low/inter-
mediate speed centrifugation steps prior to pelleting EVat
100,000 g (34,35). An initial centrifugation step of 3,000 g
was applied to clear the milk from cells and cream layer.
In comparison to the more conventional initial centrifu-
gation at lower speed (500 g), this higher g-force led
to more efficient separation of the cream layer from the
milk supernatant, whereas the efficiency of cell pelleting
and the viability of these cells were similar (data not
shown). The milk supernatant was additionally centri-
fuged at 5,000 g and 10,000 g to further remove fat and
cellular debris. Following 100,000 g centrifugation, we
observed that the EV-containing pellet was too solid to
resuspend in PBS or SDS sample buffer, which prevented
further processing and reliable analysis of these EV. The
inability to resuspend the 100,000 g pellet could be due to
highly abundant milk proteins, such as whey and casein,
which can complex and sediment at 100,000 g, forming
a compact protein matrix (19). In order to remove such
large protein complexes prior to 100,000 g pelleting, the
10,000 g milk supernatant was centrifuged into a 0.74
M/2.0 M sucrose cushion (Supplementary Fig. 1). The
EV-containing interphase was harvested, and, after cen-
trifugation at 100,000 g, the EV-containing pellet could
be resuspended. This material was overlaid with a sucrose
gradient, afterwhich EVwere separatedbased onbuoyant
densityina‘‘bottom-up’’approach(SupplementaryFig.1).
Next, the distribution and quantity of recovered ref-EV
was assessed by western blotting for mouse CD9 (mCD9)
and CD63 (mCD63). Based on previous studies in our lab,
the murine ref-EV wereexpected to equilibrate at densities
of1.121.18g/ml(32,39,41).The antibodiesusedtodetect
mCD9 and mCD63 did not cross-react with proteins
in human milk (data not shown). Although mCD9 was
observed in the expected density fractions (1.121.18
g/ml), a substantial amount of the murine EV-associated
protein stayed behind in the high density fractions (1.25
1.28 and 1.201.23 g/ml; Fig. 1a). This indicates that the
bottom-up approach for density-based purification of EV
from milk is not efficient.
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Fig. 1. Efﬁcient isolation of reference EV from breast milk by top-down density gradient ultracentrifugation. (a) Fresh human breast
milk was spiked with murine ref-EV, after which EV were recovered via bottom-up or top-down density gradient ultracentrifugation.
The distribution of recovered ref-EV over the different density fractions was analyzed by western blotting for murine CD9 (mCD9).
Indicated are the sizes for monomeric mCD9 (*,  23 kD), N-glycosylated monomeric mCD9 (**,  27 kD), and high molecular
weight complex mCD9 (***,  150 kD). This result is representative of 4 independent experiments in 3 different donors. (b) Fresh
human breast milk (h) or PBS/BSA control solution (j) were spiked with murine ref-EV, after which EV were recovered via top-
down density gradient ultracentrifugation. Fractions of the density gradient and the overlying milk supernatant were analyzed for
the presence of mCD9 and mCD63 by western blotting. Indicated are the quantiﬁed western blot signals (mean values of 2 indepen-
dent experiments in 2 different donors) normalized to the values detected in the 1.131.18 g/ml fractions of the PBS/BSA control
(set to 100%).
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purified and recovered from milk using top-down density
gradient ultracentrifugation (Supplementary Fig. 1). In
this approach, the EV-containing 10,000 g supernatant
was applied directly on top of a density gradient, thereby
circumventing the 100,000 g EV pelleting step. Following
top-down density gradient ultracentrifugation, most of
the mCD9 was present in density fractions 1.131.18 g/ml
to which the ref-EV were expected to float (Fig. 1a).
In addition to the 23 and 27 kD monomeric mCD9,
high molecular weight complexes ( 150 kD) of mCD9
were detected after top-down density gradient ultracen-
trifugation. These complexes could correspond to CD9
coupled to the b1-integrin subunit (42).
Next, we investigated to what extent the complex
composition of breast milk affected the efficiency with
which murine ref-EV could be recovered. The ref-EV
were spiked in either milk or PBS/0.1% BSA, after which
differential centrifugation and top-down density gradient
ultracentrifugation were used to isolate EV. The quantity
of ref-EV recovered from the 2 different fluids was
determined by western blotting for mCD9 and mCD63.
AsimilardistributionofmCD9andmCD63 wasobserved
over the different density fractions for EVrecovered from
breast milk and PBS/BSA, with the majority of signal
detected in the 1.131.18 g/ml density fraction (Fig. 1b).
The quantity of mCD9 recovered from both solutions
was similar, whereas slightly less CD63 was recovered
from milk compared to PBS/BSA (Fig. 1b). This could be
explained by the disparate presence of CD9 and CD63
on different subsets of the ref-EV sample. Based on these
data, weconclude that top-down gradient ultracentrifuga-
tion is an efficient method for isolation of EV from breast
milk.
Native breast milk EV are heterogeneous in size and
composition
To confirm that the top-down procedure described
above allowed isolation of EV naturally present in human
breast milk, unspiked milk samples were subjected to top-
down gradient ultracentrifugation and analyzed for the
presence of human EV-associated proteins. Western blot
analysis of human CD63 (hCD63), human CD9 (hCD9),
flotillin-1, and HLA class II showed that these proteins
were present in the same density fractions as the mouse
reference EV (Fig. 2a). Next, we investigated in more
detail whether our top-down procedure separated milk
EV from milk-specific proteins known to be abundantly
present in breast milk. For these experiments, individual
gradient fractions rather than pools of fractions were
tested. Coomassie blue staining of proteins in the different
gradient fractions showed that differently sized proteins
distributed unequally over the gradient fractions, with
some proteins being predominantly present in the high
density bottom fractions and some in the EV containing
fractions at lowerdensities (Fig. 2b). Western blotanalysis
was performed to investigate the presence of the 3 major
milk proteins b-casein, lactoferrin, and a-lactalbumin in
the different gradient fractions (Fig. 2c). To visualize
the location of EV within the gradient, the fractions
were also stained for the EV-associated markers HLA
class II, hCD63, and hCD9. We observed that b-casein
was predominantly present in the high-density fractions
of the gradient. In contrast, a-lactalbumin did not migrate
into the density gradient, but was abundantly present
in the supernatant on top of the gradient (data not
shown). The majority of lactoferrin was also present in
this supernatant (data not shown). Interestingly, a small
amount of lactoferrin was detected in the EV-containing
density fractions (Fig. 2c). These data indicate that milk
proteins that easily form aggregates or micelles, such as
b-casein, are high in density and sediment towards the
bottom of the gradient. Smaller soluble proteins, such
as a-lactalbumin and lactoferrin, do not migrate into the
density gradient, although some lactoferrin appeared to
be associated to EV.
To visualize and further characterize the size and
morphologyofbreastmilkEVinthelow-densityfractions,
EV were labeled with Annexin V-conjugated gold nano-
particles and analyzed by cryo-EM. Both the 1.121.18
and 1.181.21 g/ml density fractions contained EV,
which appeared as spherical structures within the porous
carbon film (Fig. 3ad). The ratios between Annexin
V-positive and -negative EV populations were similar in
bothdensities (Fig. 3ad).Furthermore, theratiobetween
small (B200 nm) and large ( 200 nm) EV was   4:1 in
the1.121.18g/mlfraction,and  2:1inthe1.181.21g/ml
fraction. In addition to EV, the 1.121.18 g/ml fractions
containedtubularstructures(Fig.3eg).Thesetubulesdid
not stain with Annexin V, were enclosed by a lipid bilayer,
and had a smooth appearance. The tubular structures
did not contain striations typical for the presence of actin
filaments andwere approximately 5 times more prominent
in the 1.121.18 g/ml as compared to the 1.181.21 g/ml
fraction. However, it should be noted that quantitative
analysis of EM samples is difficult due to potential bias
for larger objects, which are more easily retained within
the perforated carbon film. The data presented here are
basedonassessing50100EVperdensityfraction.Results
were comparable in 2 different donors. Taken together,
these data suggest that a heterogeneous population of
native breast milk EV can be isolated using top-down
gradient ultracentrifugation.
Storage of breast milk samples induces milk cell
death and contamination of the naturally present
EV population
Breast milk is often stored in the refrigerator (48C) or
freezer (20 or 808C) for the purpose of feeding
the infant, as well as for research. Here, the effects of
Marijke I. Zonneveld et al.
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investigated.
Fresh breast milk was either processed immediately
(within 20 minutes after collection) or stored for 2 hours
at 808Co r4 8C (Fig. 4a and b) prior to processing.
First, the number of viable human breast milk cells in
freshversusstoredmilkwasassessed.Thenumberofviable
cells present in breast milk immediately after collec-
tion was largely donor-dependent with a mean cell count
of 2.292.110
5 cells/ml (mean9SD). As expected,
the number of viable cells was strongly decreased in milk
stored at 808C (Fig. 4a). Remarkably, however, the
number of viable cells also declined significantly after
storage for 2 hours at 48C (Fig. 4b). Although the strength
of the effect varied between milk samples of different
donors, the reduction in milk cell viability upon cold
storage was observed in all milk samples tested. The
decrease in cell viability during storage at above zero
temperatures was not specific for 48C, since storage for
2hoursatroomtemperatureor378Cinducedsimilarlevels
of cell death (Supplementary Fig. 2).
Cell death and consequent formation of cell debris can
affect the composition of the total pool of milk EV.
However, unique markers to distinguish (apoptotic) vesi-
cles released by dying cells from EV actively released by
viable cells are lacking. To determine whether cell death
induced by cold storage led to contamination of the milk
EVpopulation,freshbreastmilk sampleswerespikedwith
a)
c)
b)
10 kD
15 kD
20 kD
25 kD
37 kD
50 kD
75 kD
100 kD
150 kD
250 kD
1,26 g/mL 1,08 g/ml
Lactoferrin
β-casein
HLA class II
hCD63
hCD9
1,26 g/mL 1,08 g/ml
HLA class II
hCD9
Density  (g/ml)
hCD63
Flotillin-1
1,23
-
1,27
1,22
-
1,18
1,16
-
1,12
1,11
-
1,06
23 kD
26 kD
47 kD
37 kD
26 kD
37 kD
23 kD
25 kD
70 kD
Fig. 2. Unequal distribution of native breast milk EV and major milk proteins over density gradient fractions. Fresh, unspiked human
breast milk was subjected to top-down density gradient ultracentrifugation, after which the material in the different density fractions
was harvested and analyzed. (a) Density fractions were pooled as indicated and analyzed for the recovery of native human breast milk
EV by western blotting for human CD63 (hCD63), CD9 (hCD9), ﬂotillin-1, and HLA class II. Results for hCD9 and HLA class II are
representative of 10 independent experiments in 8 different donors; results for hCD63 and ﬂotillin-1 represent 2 independent
experiments in 2 different donors. (b, c) The protein content of individual density fractions was assessed by Coomassie blue staining
(representative of 2 different donors) (b) and by western blotting for HLA class II, hCD63, hCD9, b-casein, and lactoferrin
(representative of 3 different donors) (c).
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(page number not for citation purpose)in vitro cultured dendritic cells of murine origin (hereafter
referredtoasref-cells). The milkwastheneither processed
immediately or stored at 808C. First, the percentage of
ref-cell death in breast milk in response to freezing was
determined by analyzing the number of propidium iodide
and/or Annexin V positive cells by flow cytometry.
Although the murine ref-cells appeared more robust than
the human milk cells, 2850% of the spiked cells died or
underwent apoptosis due to freezing (Fig. 4c). Next, we
investigated whether this storage method led to contam-
ination of the pool of actively released milk EV with
vesicles induced upon cold storage of the murine cells in
milk. EV were isolated from immediately processed or
frozen spiked milk samples and tested for the presence of
mCD9 and mMHC class II. Although immediately
processed control samples were typically not negative
for the murine EV markers, a significant increase in
mCD9 (22225%) and mMHC class II (1862,222%)
signals was observed in the milk EV population after
storage at 808C compared to immediately processed
milk samples (Fig. 4d and e). These data indicate that a
newly formed pool of vesicles, released by cells in milk
during cold storage, contaminated the pool of EV
naturally present in breast milk.
500 nm
e
50 nm
g
c
CF
CF
500 nm
d
200 nm
f
500 nm
a
CF
200 nm
b
50 nm
Fig. 3. Native breast milk EV are heterogeneous in size and composition. Fresh, unspiked human breast milk was subjected to top-
down density gradient ultracentrifugation, after which the material from density fractions 1.121.18 and 1.181.21 g/ml was labeled
with Annexin V-conjugated gold nanoparticles and analyzed by cryo-EM. (a, b, c, d) Representative and close up images of Annexin V
positive and negative EV in the (a, b) 1.121.18 g/ml and (c, d) 1.181.21 g/ml density fraction. (e, f) Representative images of smooth
tubular structures predominantly present in the 1.121.18 g/ml fraction, with (g) close up image of indicated ﬁeld in (f). CFcarbon
ﬁlm. Data are representative of 3 independent experiments and 2 different milk donors.
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is an alternative method for efficient and reliable EV
recovery
The release of storage-induced vesicles may be circum-
vented by clearing milk from cells as soon as possible
after milk collection and prior to cold storage. Fresh
breast milk spiked with murine ref-EV was cleared from
cells and cream layer by 2 centrifugation steps at 3,000 g,
after which EV were isolated from the milk supernatant
either immediately or after storage for at least 2 weeks
at 808C. The quantity of recovered ref-EV was as-
sessed by western blot analysis of mCD9 and mCD63.
No significant differences were found in the amount of
mCD9 and mCD63 recovered from freshly processed
and stored milk supernatant (Fig. 5a and b). These data
indicate that freezing milk supernatant devoid of cells
and cream layer can be used to store breast milk samples
for efficient recovery and reliable analysis of EV at later
time points.
Discussion
We here gained insight into parameters affecting the
recovery of EV from (stored) human breast milk samples.
Differential centrifugation followed by top-down density
gradient ultracentrifugation resulted in efficient and
reliable isolation of EV from breast milk. In addition,
we showed that freezing of unprocessed milk samples,
comprising avariety of milk cell types and cream-forming
MFG, led to contamination of the natural milk EV
population with EV induced by the storage process.
An alternative storage protocol was proposed in which
milk supernatant cleared of cells and most of the MFG
was frozen for efficient and reproducible recovery of EV
in breast milk at later time points.
EV isolation
Marker proteins for the discrimination of EV, MFG, and
cellular debris in human milk are currently lacking. An
additional complicating factor in the field of milk research
Fig. 4. Cell death in stored breast milk samples leads to contamination of the milk EV population. (a, b) Cells were isolated from fresh
or stored breast milk and their viability was assessed by trypan blue exclusion. Number of viable cells determined in fresh milk samples
and after storage (a) for 2 hours at 808C( n 6 different donors) or (b) for 2 hours at 48C( n 9 different donors). (c, d, e) Fresh
breast milk was spiked with murine cells, after which cells or EV were recovered immediately or after storage at 808Cf o r]2 weeks.
(c) Flow cytometric analysis of the percentage of dead murine cells in culture medium, or in fresh or stored breast milk samples. Box
plots show mean9SD of 3 independent experiments in 5 donors. (d, e) EV were recovered from breast milk samples by top-down
density gradient ultracentrifugation. Contamination of the breast milk EV population with vesicles induced upon sample storage was
assessed by western blot detection of murine EV markers. Indicated are the quantiﬁed western blot signals for (d) mCD9 and (e)
mMHC class II (mCD9 n7; mMHC class II n6). *pB0.05; **pB0.01.
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to the protein, fat, and cellular content of milk. Hence,
the yield of breast milk EV using different EV isolation
protocols could not be compared based on detection of
human EV-associated markers. To overcome this problem,
we spiked breast milk with a well-characterized murine
EV population. By profiling defined murine EV-associated
proteins, different protocols could be compared for the
recovery of EV from human breast milk samples derived
from a range of different donors.
A major difference between the 2 EV isolation proto-
cols tested here was the presence or absence of a high-
speed centrifugation step (100,000 g) to sediment EV.
In our hands, the 100,000 g sedimented material formed
a gelatinous pellet that could not be resuspended, as was
also observed in several other milk EV studies (13,43).
This gelatinous pellet is most likely caused by condens-
ing of casein micelles and the globular nature of the
abundantly present whey proteins, which can form gel-
like matrices under high mechanical pressure (44). Others
have applied a filtration step of the milk supernatant
prior to the EV pelleting step, and a subsequent overnight
incubation step to desolidify the pellet (9). However,
using filtration to remove large protein complexes from
the milk supernatant entails a high risk for selective
loss of EV subpopulations. As an alternative approach,
we have cleared the 10,000 g breast milk supernatant of
abundant protein complexes using a sucrose cushion.
This step was followed by a 100,000 g EV pelleting step
and bottom-up floatation of EV into a density gradient.
Using this protocol, however, a substantial amount of EV
still did not efficiently reach their expected buoyant
density of 1.121.18 g/ml. This could be explained by
trapping of EV within residual protein complexes that
still contaminated the EV pellet. This bottom-up proto-
col, including the sucrose cushion, was compared to top-
down density gradient ultracentrifugation. In this case,
the 10,000 g milk supernatant was applied directly on top
of a density gradient, thereby circumventing the 100,000
g pelleting step. Using this procedure, the majority of
spiked murine EVreached their expected buoyant density.
Moreover, recovery of the spiked EV from breast milk
samples was as effective as from PBS, indicating that the
complexity of milk did not hamper quantitative recovery
of EV from milk.
The use of spiked reference murine EV allowed close
monitoring of the efficiency of different protocols for
isolation of EV from milk. However, we cannot fully
exclude that spiked murine EV and naturally occurring
human breast milk EV behaved differently in these
procedures. Nevertheless, we confirmed the presence of
native human breast milk EVin the same density fractions
as the spiked reference murine EV using western blot
and cryo-EM (Figs. 2 and 3). Interestingly, the breast
milk EV floating to the different densities contained
relatively different amounts of HLA class II, hCD63
and hCD9. The different distributions of these EV-
associated proteins over the gradient, which has also
been observed for EV derived from tumour cells (45),
indicate that the protein composition of breast milk EV is
heterogeneous. Most of the major milk proteins separated
from EV, either by sedimentation towards the bottom
of the gradient, or because these proteins did not migrate
into the gradient. A minor proportion of beta-casein
and lactoferrin co-localized with EV markers. Whether
this denotes small-scale contamination of the EV frac-
tions with these proteins or whether a small amount of
these proteins is physically associatedwith EV is currently
unknown.
By using cryo-EM analysis, we demonstrated that
the human breast milk EV population was very hetero-
geneous with regard to size, electron density, and
Annexin V labeling. With regard to Annexin V labeling,
which detects exposed phosphatidylserine (PS), EV were
either highly positive or fully negative. This difference
in apparent loss of phospholipid asymmetry in the
lipid bilayer of these 2 subtypes of EV might reflect a
difference in their biogenesis. Besides EV, lipid bilayer
enclosed tubules were identified, which were markedly
enriched in the 1.121.18 g/ml density fraction (Fig. 3eg),
while being almost absent in the higher density (1.181.21
g/ml) EV-containing fractions and the lowest density
fractions (1.101.04 g/ml, data not shown). These tubules
were homogenous in diameter ( 100 nm) and nega-
tive for Annexin V staining. Their smooth appearance
suggests a lipid core, as striations typical for actin-like
filaments were lacking. The tubes observed in human
mCD9
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Fig. 5. Milk supernatant cleared from cells and cream can
be stored for efﬁcient and reliable recovery of EV. Fresh breast
milk was spiked with murine reference EVand centrifuged twice
to remove cells and cream. EV were recovered from milk
supernatant before (j) and after (h) storage at 808Cf o r
28 weeks and analyzed by western blotting for the presence of
(a) mCD9 and (b) mCD63. Indicated are the quantiﬁed western
blot signals (mean9SD) normalized to the values detected in
unstored milk supernatant (set to 100%). mCD9 n 5; mCD63
n 4. n.s.not signiﬁcant.
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in platelet-free plasma (46) and are currently under
further investigation.
Storage of milk samples
Until now, most studies on human and bovine milk EV
have utilized frozen or refrigerated unprocessed milk
(912,2124). Although the effects of sample storage on
recovery of EV from blood plasma has been well docu-
mented(reviewedin16),storageeffectsonEVinmilkhave
not been studied in detail. We here showed that storage of
unprocessed milk, especially at sub-zero temperature, led
to massive death of milk cells. Spiking human breast milk
with cells of murine origin allowed us to monitor the
induction of storage-induced EV. Upon storage of spiked
milk samples we found a large increase in the recovery
of murine EV corresponding to an increase in murine
cell death. These data indicated that storage-induced
stress or death of cells in milk induced EV formation,
therebycontaminating the pool of native milk EV. Despite
thorough washing of the murine cell preparations used to
spike milk samples, low levels of murine EV could also
be recovered from fresh spiked milk samples. This could
be explained by rapid stimulation-induced release of EV
(47) caused by mechanical stress imposed on cells during
harvestingfromtheinvitrocultures.Alternatively,dyingor
dead cells present in the murine cell population at the time
of spiking could have led to detectable contamination in
the EV population.
In contrast to the predictable death of cells caused by
freezingofmilksamples,thelarge-scalecelldeathdetected
in milk stored at RTand 48C was unexpected (Fig. 4a and
b, Supplementary Fig. 2). This cell death may be caused
by the action of multiple proteases and lipases, with bile-
salt-stimulated lipase (BSSL) being one of the most
prominent lipases in milk. It has been described that
BSSL loses its dependencyon bile salt at low temperature,
rendering it constitutively active (48,49). This could
cause cells in milk to lose their membrane integrity and
die. Besides cells being a source of storage-induced EV,
contamination of the EV population might also occur
by storage-induced MFG fragmentation. Although the
withdrawal, processing and storage of body fluids will
always affect the fluid composition to a certain extent,
these effects should be kept to a minimum to allow for
accurate analysis of EV naturally present in body fluids.
Previous studies demonstrated that it is difficult to
discriminate EV from apoptotic bodies and cell debris
based on protein profile. Although some proteins (e.g.
histones) are more abundant in apoptotic bodies, a large
numberofproteinsabundantlypresentinEVfromhealthy
cells, such as MHC class II, also occur in apoptotic bodies
and cell debris (29). Together with our results, this
emphasizes the necessity to remove potential sources of
storage-induced EV, such as cells and MFG present
in milk, as soon as possible after collection of the body
fluid.Theimpactofourfindingsontheconclusionsdrawn
in previous studies on stored breast milk samples is
unknown. Some of the observed effects in these studies
could have been due to cell debris, while other EV-specific
effects could have been missed. In conclusion, the data
presented here provide new insights into storage and
isolation methods for breast milk EV. This knowledge
can be used to further elucidate the role of breast milk
EV in development of the infant immune system and for
EV-based biomarker studies in breast milk.
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